Plain-English translation of NCT07223749 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Wake Forest University have created a computer tool designed to spot early signs of COPD — a chronic lung disease — by analyzing existing patient medical records. This study will validate whether the tool works accurately in a real-world patient population. The goal is to help identify people with COPD early, when treatment can be most effective.
Many people have COPD without knowing it, especially those who may not report symptoms or haven't seen a doctor recently. Current screening methods rely on questionnaires that aren't practical for widespread use. This research aims to create an automated, efficient way to identify high-risk patients so they can receive early treatment.
You likely qualify if…
You likely don't qualify if…
Your participation involves allowing researchers to review your existing medical records and health information already stored in the hospital system. There are no medications to take, no hospital visits required, and no physical procedures. The study simply validates whether the computer tool can accurately predict COPD risk based on your records.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Enrollment target
~500 participants
Started
August 2025
Primary completion
August 2026
Age range
40 Years and older
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Brian J Wells, MD
Wake Forest University Health Sciences
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.